Neurotrophins as regulators of urinary bladder function (Q38050405)

27 August 2017

title

Neurotrophins as regulators of urinary bladder function (English)

1 reference

27 August 2017

Célia D Cruz

2

0 references

Francisco Cruz

object named as

Francisco Cruz

series ordinal

4

0 references

author name string

Peter Ochodnicky

series ordinal

1

1 reference

27 August 2017

Naoki Yoshimura

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

9 October 2012

1 reference

27 August 2017

published in

Nature Reviews Urology

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

628-637

1 reference

The neural control of micturition

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Overactive bladder: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Afferent nerve regulation of bladder function in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Bladder afferent signaling: recent findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Bladder Pain Syndrome Committee of the International Consultation on Incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

The uroepithelial-associated sensory web.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Mechanisms of disease: involvement of the urothelium in bladder dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Neurotrophins: mediators and modulators of pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Detrusor myocyte activity and afferent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

On the origins of the sensory output from the bladder: the concept of afferent noise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Expression of neurotrophin messenger RNAs during rat urinary bladder development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Developmental expression of urinary bladder neurotrophic factor mRNA and protein in the neonatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

The nerve growth factor 35 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve growth factor responsiveness of cultured major pelvic ganglion neurons from the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Mast cells differentially express and release active high molecular weight neurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve growth factor: a neurokine orchestrating neuroimmune-endocrine functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Substance P induced release of macrophage migration inhibitory factor from rat bladder epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Antagonism of nerve growth factor-TrkA signaling and the relief of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Sensitisation of visceral afferents by nerve growth factor in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

The role of nerve growth factor in a model of visceral inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Functional transient receptor potential vanilloid 1 is expressed in human urothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Functions of the neurotrophins during nervous system development: what the knockouts are teaching us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Peripherally-derived BDNF promotes regeneration of ascending sensory neurons after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Neurotrophin/receptor expression in urinary bladder of mice with overexpression of NGF in urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Interstitial cystitis: an unsolved enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Characteristics of Mast Cells in Normal Bladder, Bacterial Cystitis and Interstitial Cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Cystitis, co-morbid disorders and associated epithelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

New theories in interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Plasticity in reflex pathways to the lower urinary tract following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Therapy Insight: bladder dysfunction associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Changes in galanin immunoreactivity in rat lumbosacral spinal cord and dorsal root ganglia after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Regulation of nerve growth factor secretion in smooth muscle cells cultured from rat bladder body, base and urethra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve growth factor induces P2X(3) expression in sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

The detrusor muscle: an innocent victim of bladder outlet obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve growth factor and vanilloid receptor expression, and detrusor instability, after relieving bladder outlet obstruction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Overexpression of epithelial sodium channels in epithelium of human urinary bladder with outlet obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Role of urothelial nerve growth factor in human bladder function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Diabetic bladder dysfunction: current translational knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Increased levels of nerve growth factor in the urinary bladder and hypertrophy of dorsal root ganglion neurons in the diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Multipotent neurotrophin antagonist targets brain-derived neurotrophic factor and nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Novel class of pain drugs based on antagonism of NGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

BDNF: a neuromodulator in nociceptive pathways?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

883 URINARY LEVELS OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) IN WOMEN WITH OVERACTIVE BLADDER (OAB) SYNDROME CORRELATE WITH THE SEVERITY OF SYMPTOMS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Histological and neurotrophic changes triggered by varying models of bladder inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Transient receptor potential vanilloid 1 mediates nerve growth factor-induced bladder hyperactivity and noxious input

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve fibre proliferation in interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Nerve Growth Factor and Pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Protein kinase C in cyclic stretch-induced nerve growth factor production by urinary tract smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Bladder dysfunction in type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Chronic prostatitis/chronic pelvic pain: the syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

The role of endogenous nerve growth factor in human diabetic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Biomarkers in overactive bladder: a new objective and noninvasive tool?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Anti-NGF painkillers back on track?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.178

The ultrastructure of bladder lamina propria nerves in healthy subjects and patients with detrusor hyperreflexia

31 March 2020

1 reference

12 December 2020

Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence

1 reference

12 December 2020

Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats

1 reference

12 December 2020

Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients

1 reference

12 December 2020

Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in women

1 reference

12 December 2020

Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia

1 reference

12 December 2020

Can urinary nerve growth factor be a biomarker for overactive bladder?

1 reference

12 December 2020

Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2012.178

1 reference

Dimensions Publication ID

27 August 2017

1011076694

0 references

1 reference